A nomogram for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma based on spleen-volume-to-platelet ratio

被引:4
|
作者
Meng, Xue-Qin [1 ]
Miao, Hui [2 ]
Xia, Yong [3 ]
Shen, Hao [3 ]
Qian, Yi [1 ]
Chen, Yan [1 ]
Shen, Feng [3 ]
Guo, Jia [1 ,4 ]
机构
[1] Second Mil Med Univ, Naval Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Ultrasound, Shanghai, Peoples R China
[2] Second Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Shanghai, Peoples R China
[3] Shanghai Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 4, Shanghai, Peoples R China
[4] Second Mil Med Univ, Shanghai Eastern Hepatobiliary Surg Hosp, Dept Ultrasound, 225 Changhai Rd, Shanghai 200438, Peoples R China
关键词
Post-hepatectomy liver failure; Spleen volume -to -platelet ratio; Liver resection; Hepatocellular carcinoma; HEPATIC RESECTION; PREALBUMIN; DISEASE; COUNT; DEFINITION; SURGERY; INDEX;
D O I
10.1016/j.asjsur.2022.05.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background and objectives: Post-hepatectomy liver failure (PHLF) is one of the most serious complica-tions after hepatectomy in patients with hepatocellular carcinoma (HCC), and has an association with high morbidity and mortality. This study aimed to explore the risk factors of PHLF and to establish and validate a nomogram to predict PHLF.Methods: We retrospectively analyzed 971 HCC patients undergoing major liver resection at the Eastern Hepatobiliary Surgery Hospital between 2011 and 2016, and established a nomogram based on multi-variate analyses for predicting PHLF. The predictive accuracy and discriminative ability of the nomogram were evaluated by concordance index (C-index) and calibration curve. The predictive ability of PHLF of this nomogram was compared with conventional models using receiver operating characteristic (ROC) curves.Results: The incidence of PHLF was 18.8%. Multivariate analysis identified age, BMI, preoperative ascites, preoperative prealbumin, spleen volume-to-platelet ratio, total bilirubin, and intraoperative blood loss as independent predictors of PHLF. The area under ROC curve (AUROC) of the predictive model was 0.668 and was higher than that of the albumin-bilirubin score (ALBI). The optimal cut-off value of the model was 124.Conclusions: We constructed a nomogram for predicting PHLF based on risk factors. The nomogram can assist clinicians in identifying patients with high-risk PHLF, eventually facilitating earlier interventions and improving clinical outcomes.& COPY; 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页码:399 / 404
页数:6
相关论文
共 50 条
  • [1] Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram
    Haiyi Long
    Chuan Peng
    Hong Ding
    Yun Zheng
    Jianhua Zhou
    Wei Chen
    Xian Zhong
    Yifan Shi
    Yu Duan
    Xiaohua Xie
    Ming Kuang
    Xiaoyan Xie
    Manxia Lin
    European Radiology, 2023, 33 : 7665 - 7674
  • [2] Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram
    Long, Haiyi
    Peng, Chuan
    Ding, Hong
    Zheng, Yun
    Zhou, Jianhua
    Chen, Wei
    Zhong, Xian
    Shi, Yifan
    Duan, Yu
    Xie, Xiaohua
    Kuang, Ming
    Xie, Xiaoyan
    Lin, Manxia
    EUROPEAN RADIOLOGY, 2023, 33 (11) : 7665 - 7674
  • [3] Nomogram based on CT–derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma
    Yangling Peng
    Hesong Shen
    Hao Tang
    Yuanying Huang
    Xiaosong Lan
    Xianzhang Luo
    Xiaoyue Zhang
    Jiuquan Zhang
    European Radiology, 2022, 32 : 8529 - 8539
  • [4] Novel nomogram model for predicting severe post-hepatectomy liver failure risk in patients with resectable hepatocellular carcinoma
    Rongyun Mai
    JiazhouYe
    Zhongrong Long
    Xianmao Shi
    Tao Bai
    Lequn Li
    Feixiang Wu
    Guobin Wu
    Cancer Biology & Medicine, 2018, 15(S1) (S1) : 22 - 23
  • [5] Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma
    Peng, Yangling
    Shen, Hesong
    Tang, Hao
    Huang, Yuanying
    Lan, Xiaosong
    Luo, Xianzhang
    Zhang, Xiaoyue
    Zhang, Jiuquan
    EUROPEAN RADIOLOGY, 2022, 32 (12) : 8529 - 8539
  • [6] Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection
    Bae, Jae Seok
    Lee, Dong Ho
    Yoo, Jeongin
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    Kim, Haeryoung
    Lee, Kyung Bun
    EUROPEAN RADIOLOGY, 2021, 31 (04) : 2461 - 2471
  • [7] Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection
    Jae Seok Bae
    Dong Ho Lee
    Jeongin Yoo
    Nam-Joon Yi
    Kwang-Woong Lee
    Kyung-Suk Suh
    Haeryoung Kim
    Kyung Bun Lee
    European Radiology, 2021, 31 : 2461 - 2471
  • [8] A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
    Wang, Jitao
    Zhang, Zhanguo
    Shang, Dong
    Liao, Yong
    Yu, Peng
    Li, Jinling
    Chen, Shubo
    Liu, Dengxiang
    Miao, Hongrui
    Li, Shuang
    Zhang, Biao
    Huang, Anliang
    Liu, Hao
    Zhang, Yewei
    Qi, Xiaolong
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 901 - 912
  • [9] Interpretable machine learning model for predicting post-hepatectomy liver failure in hepatocellular carcinoma
    Tianzhi Tang
    Tianyu Guo
    Bo Zhu
    Qihui Tian
    Yang Wu
    Yefu Liu
    Scientific Reports, 15 (1)
  • [10] Association Between Procalcitonin and Post-hepatectomy Liver Failure in Hepatocellular Carcinoma Patients
    Li, Yi-Ran
    Meng, Xiao-Yan
    Zong, Rui-Qing
    Wu, Fei-Xiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12